BamSEC and AlphaSense Join Forces
Learn More

Pyxis Oncology Inc. – Indentures

NASDAQ: PYXS    
Share price (6/2/26): $1.71    
Market cap (6/2/26): $108 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from S-3 38 pages Pyxis Oncology, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.1
from 10-K 5 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 23 pages Pre-Funded Common Stock Purchase Warrant Pyxis Oncology, Inc
12/34/56
EX-4.7
from POS AM 14 pages Warrant Agreement to Purchase Shares of the Series C Preferred Stock of Apexigen, Inc. Dated as of April 23, 2004
12/34/56
EX-4.6
from POS AM 5 pages Warrant Assignment, Assumption and Amendment Agreement
12/34/56
EX-4.5
from POS AM 24 pages Brookline Capital Acquisition Corp. and Continental Stock Transfer & Trust Company Amended and Restated Warrant Agreement
12/34/56
EX-4.5
from S-8 POS 21 pages Apexigen, Inc. 2022 Equity Incentive Plan
12/34/56
EX-4.4
from POS AM 41 pages Warrant Assumption Agreement
12/34/56
EX-4.3
from POS AM 18 pages Placement Agent Common Stock Purchase Warrant Apexigen, Inc
12/34/56
EX-4.4
from S-8 POS 17 pages Apexigen, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.2
from POS AM 17 pages Common Stock Purchase Warrant Apexigen, Inc
12/34/56
EX-4.5
from S-8 21 pages Apexigen, Inc. 2022 Equity Incentive Plan
12/34/56
EX-4.3
from S-8 POS 16 pages Apexigen, Inc. 2010 Equity Incentive Plan as Amended on November 24, 2017
12/34/56
EX-4
from 10-K 6 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-3 38 pages Pyxis Oncology, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.3
from S-8 2 pages Pyxis Oncology, Inc. 2022 Inducement Plan
12/34/56
EX-4.1
from 10-K 6 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-8 9 pages Pyxis Oncology, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-4.4
from S-8 22 pages Pyxis Oncology, Inc. 2021 Equity and Incentive Plan Adopted by the Board of Directors: September 24, 2021 Approved by the Stockholders: September 30, 2021 Termination Date: September 27, 2031 I. Introduction
12/34/56
EX-4.3
from S-8 18 pages Pyxis Oncology, Inc. 2019 Stock Plan Adopted on June 27, 2019
12/34/56